药康生物：两期回购后实施差异化分红拟派现1226.91万元

Core Viewpoint - The company has completed a total of 3.07 million shares repurchase under two phases of its buyback plan, indicating a commitment to returning value to shareholders [1] Group 1: Share Buyback - The company completed the repurchase of 1.58 million shares on June 6, 2025, and 460,000 shares on October 27, 2025, as part of its employee stock ownership plan [1] - As of the date of the verification opinion, the company holds 1.03 million shares in its dedicated repurchase account [1] Group 2: Dividend Distribution - The company plans to implement a differentiated dividend distribution for the first half of 2025, proposing a cash dividend of 0.3 yuan (including tax) for every 10 shares, based on a total of 40.897 million shares [1] - The total cash dividend to be distributed amounts to 12.2691 million yuan [1] - The sponsor believes that this differentiated dividend distribution complies with regulations and does not harm the interests of the company and its shareholders [1]